@article{ART003282908},
author={Jiyeon Jang},
title={A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT)},
journal={CELLMED},
issn={3022-6805},
year={2025},
volume={15},
number={16},
pages={3-3},
doi={10.5667/CellMed.spc.151}
TY - JOUR
AU - Jiyeon Jang
TI - A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT)
JO - CELLMED
PY - 2025
VL - 15
IS - 16
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 3
EP - 3
SN - 3022-6805
AB - Objective: Blood contains lipid components, such as cholesterol and triglycerides. However, when these components exceed the normal range, dyslipidemia can be diagnosed, and it may be classified into several subcategories depending on which lipid parameter is abnormal. This condition is closely associated with cardiovascular disease and can lead to substantial socioeconomic losses by increasing individual burden, reducing productivity, and elevating mortality. Therefore, once dyslipidemia is recognized, it is important to implement appropriate treatment.
Case Report: This case involved a Korean woman in her 50s who was found to have dyslipidemia due to elevated triglyceride levels on a routine health screening. She also showed abnormal findings consistent with prediabetes, gastritis, and esophagitis, and she reported discomfort related to these conditions. Therefore, Ortho-Cellular Nutrition Therapy (OCNT) was implemented using ginger extract, berberine, medium-chain fatty acids, curcumin, mother of vinegar, taurine, and glutathione. Following the intervention, triglyceride and glycated hemoglobin levels returned to the reference range, and the patient reported improvement in symptoms that had previously caused discomfort.
Conclusion: Because this report describes a single patient, the same OCNT regimen may not be applicable to all patients with dyslipidemia. Nevertheless, appropriately individualized OCNT may help improve dyslipidemia and mitigate related abnormalities and discomforting symptoms.
KW - Ortho-Cellular Nutrition Therapy (OCNT);Dyslipidemia;Triglycerides;Fatty acids;Bile acids
DO - 10.5667/CellMed.spc.151
ER -
Jiyeon Jang. (2025). A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT). CELLMED, 15(16), 3-3.
Jiyeon Jang. 2025, "A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT)", CELLMED, vol.15, no.16 pp.3-3. Available from: doi:10.5667/CellMed.spc.151
Jiyeon Jang "A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 15.16 pp.3-3 (2025) : 3.
Jiyeon Jang. A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT). 2025; 15(16), 3-3. Available from: doi:10.5667/CellMed.spc.151
Jiyeon Jang. "A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 15, no.16 (2025) : 3-3.doi: 10.5667/CellMed.spc.151
Jiyeon Jang. A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT). CELLMED, 15(16), 3-3. doi: 10.5667/CellMed.spc.151
Jiyeon Jang. A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT). CELLMED. 2025; 15(16) 3-3. doi: 10.5667/CellMed.spc.151
Jiyeon Jang. A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT). 2025; 15(16), 3-3. Available from: doi:10.5667/CellMed.spc.151
Jiyeon Jang. "A Case Report of Dyslipidemia Improvement Through Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 15, no.16 (2025) : 3-3.doi: 10.5667/CellMed.spc.151
